Background: Feline calicivirus (FCV) is a common pathogen causing widely prevalent upper respiratory disease for kitten and felines in recent years. Due to the substantial genetic variability of the viral genes, existing vaccines cannot provide complete protection. Therefore, researches on FCV antiviral drugs have received much attention.
FCV was considered to have only one serotype [11] . Therefore, it is necessary to develop a safe and effective antiviral drug as a monotherapy or as part of a combination treatment.
In previous studies, various compounds had been found to have anti-FCV effects, such as minomorpho oligophosphate (PMO), lithium chloride, and germacrone [12] [13] [14] . The combination of mefloquine and recombinant cat interferon-ω had a synergetic effect against FCV [15] . Copper is an indispensable element used in the production of livestock and poultry. Basic copper chloride is an essential additive in feed. Researchers previously found that copper and copper compounds had antiviral effects against dengue virus, influenza virus, and human immunodeficiency virus (HIV) in vitro [16] [17] [18] . The copper(II) chloride complex has also been used for anticancer effects in vitro in human cell lines of cervical cancer, colon cancer, ovarian cancer, and melanoma [19] . However, there have been no reports on the antiviral effect of copper chloride against FCV.
In this study, we found that copper chloride induces low cytotoxicity in F81 cells. We evaluated the antiviral effects of copper chloride in vitro in a dose-dependent manner by measuring the TCID 50 and using RT-qPCR to analyse the effects against FCV. Additionally, the combination of copper chloride and ribavirin showed synergistic antiviral effects against FCV.
Results

Cytotoxicity test of copper chloride on F81 cells
The results of the cytotoxicity assay showed that the relative cell viability was above 85% after treatment with copper chloride at a concentration of 20~80 μM for 24 h or 72 h.
When the concentration of the copper chloride was not higher than that of 200 μM (below CC 50 ), the relative cell viability of the F81 cells was higher than that of 50% after 24 h or 72 h of treatment, indicating that copper chloride can be regarded as non-toxic in this concentration range. Therefore, a concentration of 200 μM copper chloride was used as the maximum concentration for the antiviral experiments.
Fig. 1
Cytotoxicity assay of copper chloride to F81 cells. A CCK-8 assay was used to measured cytotoxicity to F81 cells exposed to copper chloride at concentrations of 400, 200, 100, 80, 60, 40, and 20 µM during incubation at 37 °C and 5% CO 2 for 24 h or 72 h.
The relative activity of 0.4% DMSO-treated F81 cells was considered to be 100%, and the cytotoxicity was shown as the percentage of cell activity with respect to the DMSO mimetic treatment. Each value represents three independent replicate experiments.
Antiviral effect of copper chloride at different doses
To evaluate the antiviral effects of different doses of copper chloride against FCV, we examined the virus titre and RNA levels of FCV in the F81 cells treated with different doses of copper chloride. The results showed that the virus titre was significantly lower than that of the mock group after the cells were exposed to 60, 80, 100, and 200 μM concentrations of copper chloride (p < 0.001) ( Fig. 2A ). The relative RNA levels of the FCV were significantly reduced compared to the mock group when the copper chloride concentration was 80 or 100 μM (p < 0.005), and the decrease was very significant at 200 μM (p < 0.001) ( Fig. 2B ). In addition, all the results indicated that the antiviral effect of copper chloride on the F81 cells was dose-dependent. The IC 50 of the copper chloride to FCV was determined to be 5.1 μM (Fig. 2C ). 
Indirect immunofluorescence assay
To further evaluate whether the antiviral effect of copper chloride against FCV was dosedependent, we performed an indirect immunofluorescence assay (IFA). The results showed that intense green fluorescence signal was observed in the 0 μM group, and only weak fluorescence signals were observed at the concentrations of 60, 40, and 20 μM, indicating a dose-dependent relationship after greyscale scanning ( Fig. 3B ). There was almost no fluorescence signal at the concentrations of 80, 100, and 200 μM or for the control group compared to the mock group (Fig. 3A ). In addition, the F81 cells treated with 200 μM copper chloride showed slight rounding and polymerization. This finding also validates the range of non-toxic concentrations of copper chloride previously described. 
Antiviral effect of copper chloride for different treatment times
To evaluate the antiviral effect of copper chloride to FCV at different treatment times, we examined the virus titer and RNA levels of FCV in F81 cells at different action times. The results showed that the virus titre and the relative RNA level of the FCV were significantly lower in the copper chloride treatment group after -1, 0, and 1 h of FCV infection compared with that of the mock group (p < 0.001). After 16 h of virus infection, there was no significant difference between the virus titre or relative RNA level of the FCV and the mock group, indicating that the antiviral effect of copper chloride (80 μM) was not significant after 8 h of FCV infection ( Fig. 4A and B) . The RT-qPCR data also obtained the similar results.
Fig. 4
The antiviral effect of copper chloride on FCV at different times. The F81 cells were infected with 100 TCID 50 FCV and then treated with 80 µM copper chloride for -1, 0, 1, 2, 4, 8, and 16 h. After incubation for 24 h at 37 °C and 5% CO 2 , the virus titre (A) and relative RNA levels (B) of the FCV were detected. NS, p > 0.1234; ** p <0.0021; *** p <0.0002; and **** p <0.0001.
Antiviral effect of copper chloride on different strains
For other strains of FCV, the antiviral effects of copper chloride were validated. As previously described, we determined the viral titre and relative viral RNA levels of the different strains after copper chloride treatment. The results showed that 80 μM copper chloride used to treat the other strains of FCV (CH-JL1, CH-JL3, CH-JL4, and CH-SH) isolated in ourlaboratory before [20] significantly reduced the viral titre and relative viral RNA levels of the infected F81 cells ( Fig. 5A and B) . These results indicate that copper chloride has a strong antiviral effect against strains of FCV with differing isolates.
Fig. 5
The antiviral effect of copper chloride for different FCV strains. The F81 cells were infected with different FCV strains at 100 TCID 50 and treated with 80 µM copper chloride.
After incubation for 28 h at 37 °C and 5% CO 2 , the virus titre (A) and the relative RNA levels (B) of the FCV were detected; * p < 0.1234 and ** p < 0.0021.
Synergistic effect of ribavirin and the antagonistic effect of F(ab') 2
The checkerboard method was used to mix different compounds, and the antiviral effect of the compound combination was evaluated using SynergyFinder. The results showed that the combination of copper chloride and ribavirin had a synergistic effect on the protection of FCV-infected F81 cells within a specific concentration range (Fig. 6A ). The ZIP model was used to calculate the average score for the synergy of the two compounds, and it was found to be 9.687 ( Fig. 6B) . Conversely, the combined use of copper chloride and F(ab') 2 showed antagonism, and the average score of the two compounds calculated by the ZIP model was -20.798 ( Fig. 6C and D) . 
Discussion
In previous studies, copper or copper ions had an antiviral effect on herpes simplex virus (HSV) [21] . However, they were mainly used to inactive virions since copper ions can destroy the activity of certain hydroxyl radical (OH)-containing proteins [22, 23] . However, when the concentration of the copper ions was too high, its toxicity to the organisms was fatal because copper chloride can inactivate specific proteins and induce a large number of reactive oxygen species in cells to induce apoptosis [24] . In our study, we found that low concentrations of copper chloride induced low cytotoxicity in the F81 cells. The F81 cells treated with copper chloride concentrations of less than 200 µM for 24 h and 72 h showed cell activity greater than 50%, which was similar to previously reported soluble copper chloride cytotoxicity results [25] . Previously, copper chloride dihydrate-treated DENV exhibited excellent antiviral activity but the antiviral effect of copper chloride on FCV had not been reported [26] . In this study, we found that copper chloride had an antiviral effect against FCV with an IC50 of 5.1 µM. The IFA results showed that the inhibition of FCV by copper chloride was dose-dependent and significantly reduced the cytopathic effect (CPE) caused by FCV in the F81 cells. After treatment with different concentrations of copper chloride, the viral titre and RNA expression levels of FCV were significantly different from those of the control.
Then, we demonstrated the inhibitory effect of copper chloride on the viral titre and RNA levels of FCV at different times. FCV was significantly inhibited when copper chloride was added 8 h before FCV was used to infect the cells, but copper chloride did not significantly inhibit FCV after 16 h. Because our findings differed from those of previous studies using fexaramine, LiCl, ginger extracts,or CSX [13, 14, 27, 28] , we speculated that copper chloride can inhibit the replication of FCV in cells and does not affect the adsorption or entry of the virus into the cells, but its mechanism of inhibiting replication needs further verification. We found that cupric chloride also inhibited other strains of FCV replication in the F81 cells, which is further evidence of the antiviral activity of copper chloride against FCV. In a later experiment, we found that the broad-spectrum antiviral drugs ribavirin and copper chloride have synergistic effects in inhibiting FCV. The most synergistic area scored 15.5, with an average score of 9.7. However, copper chloride and an immunoglobulin F(ab') 2 showed a robust antagonistic effect. The cupric chloride may affect the biological activity of F (ab') 2 [ 29] , resulting in antagonistic effects of the two drugs in cells infected with FCV, but more proof is needed.
Conclusions
In summary, we verified that copper chloride induced low cytotoxicity in the F81 cells and had an antiviral effect on FCV in vitro. Later, we found that copper chloride played a role in the replication stages of FCV-infected cells, and it had a synergistic effect with ribavirin, but the drug resistance should be determined in a future study. These studies further confirmed that copper chloride could be used as one of candidate drugs for developing anti-FCV agents.
Methods
Viruses, cells and compounds
The FCV CH-SH strains and F81 cells were provided by the Institute of Military Veterinary Medicine, Academy of Military Medical Science. FCV CH-JL1/CH-JL2/CH-JL3/CH-JL4 were isolated and stored in our laboratory [20] . The horse anti-FCV immunoglobulin F(ab') 2 was produced and stored in our laboratory [30] . The cupric chloride dihydrate (Aladdin, China) product number was C111685. The ribavirin (Aladdin, China) product number was R101754.
Cytotoxicity assay for copper chloride
Diluted copper chloride (100 μL per well) was added to the F81 cells at 100% confluence in a 96-well plate, and MEM containing 0.4% DMSO was used as the control. The cells were incubated at 37 ℃ and 5% CO 2 for 24 h or 72 h. After washing the cells twice with PBS solution, 180 μL of FBS-free MEM and 20 μl of CCK-8 (CCK8; Dojindo, Japan) were added to each well. After incubation at 37 ℃ for 1-2 h, the optical density (OD) was read at 450 nm using a Cmax Plus microplate reader (Molecular Devices, USA). The cell viability was calculated by the formula [OD 450 (compound) -OD 450 (blank)] / [OD 450 (control) -OD 450 (blank)] × 100%. The copper chloride concentrations that were 50% or less than the cytostatic concentration (CC 50 ) were defined as non-toxic [31] .
Virus titre and genome detection
The virus solution to be detected was diluted in a 10-fold gradient. Each concentration was added to each column at 100 μL per well, followed by the addition of 100 μL of 2% MEM. The control was established in virus-free medium and cultured at 37 °C and 5% CO 2 .
The virus TCID 50 was calculated using the Reed and Muench formula. Relative RT-qPCR was used to evaluate FCV gene expression. Briefly, first, the RNA of the virus was extracted by the Simply P total RNA extraction kit (Bioflux, China), and then, the RNA was reverse transcribed into complementary DNA (cDNA) (Thermo, USA), followed by RT-qPCR using TB Green Premix Ex Taq II (Tli RNaseH Plus) (TaKaRa China). The upstream and downstream sequences for FCV were 5′-GCAGGTTGGGATAAACATGGA-3′ and 5′-CACGAGGCGATTGAGTTGAG-3′, and for GAPDH, they were 5'-TGGAAAGCCCATCACCATC-3' and 5'-ACTCCACAACATACTCAGCACCA-3'.
Antiviral effect of copper chloride on FCV
F81 cells at 100% confluence were infected with 100 TCID 50 of FCV CH-JL2, while different concentrations of copper chloride (200~20 μM) were added to the medium. The MEM containing 0.4% DMSO was used as a mock treatment group. After incubation for 28 h at 37 °C and 5% CO 2 , the TCID 50 levels of virus and the RT-qPCR results were determined to assess the antiviral effect against FCV. The half-maximal inhibitory concentration (IC 50 ) of the copper chloride to FCV was also determined, and the results were plotted using GraphPad Prism 8.
Indirect immunofluorescence assay (IFA)
To more intuitively observe the antiviral effect of copper chloride on FCV, we performed an IFA [30] . As described above, a monolayer of F81 cells infected with 100 TCID 50 of FCV was exposed to different concentrations of copper chloride and then fixed in 80% cold acetone for 30 min. Next, the cells were washed 5 times with PBS containing 0.05% Tween-20 (PBST). Then, primary antibody (VMRD, USA) diluted 300-fold with 1% BSA was added and incubated for 1 h at 37 °C. The supernatant was discarded, and the cells washed 5 times with PBST, and a 200-fold diluted FITC-labelled rabbit anti-cat secondary antibody (Bioss Antibody, China) was added in the dark and incubated at 37 °C for 1 h.
The fluorescence was observed under an inverted Leica DMi8 fluorescence microscope (Leica, Germany), and the fluorescence results were analyzed by greyscale scanning.
Effect of different treatment times of copper chloride on FCV
To determine whether the antiviral effect of copper chloride in F81 cells was timedependent, a final concentration of 80 μM copper chloride solution was administered -1 h, 0 h, 2 h, 4 h, 6 h, 8 h, and 16 h after FCV infection. After incubation for 24 h at 37 °C and 5% CO 2 , the TCID 50 level was determined and the RT-qPCR results were assessed to determine the amount of virus.
Antiviral effect of copper chloride on different strains
To determine whether copper chloride also has antiviral effects against other FCV strains, we also diluted different strains of FCV (CH-JL1, CH-JL3, CH-JL4, and CH-SH) to 100 TCID 50 and infected the F81 cells, which were subsequently treated them with a final concentration of 80 μM copper chloride solution. After incubating the cells with virus for 28 h at 37 °C and 5% CO 2 , the TCID 50 level was determined and the RT-qPCR results were assessed to determine the amount of virus.
Combinations of copper chloride and ribavirin or F(ab') 2
To evaluate the combined action of the compounds, we diluted the different drugs by the checkerboard method and mixed the two drugs thoroughly (copper chloride and ribavirin or copper chloride and F(ab') 2 ). The results from the RT-qPCR experiments were statistically analyzed in a manner described previously, and the effects of the drug combination were evaluated using SynergyFinder [32] . The zero-interaction-efficiency (ZIP) model [26] was used to calculate the mutual scores of the different concentrations of the drug. For each treatment, at least three triplicate data sets from independent experiments were analyzed. The results are expressed as the mean and mean standard error (SEM).
Statistical methods
All experiments were performed three times independently in triplicate. The data were expressed as the mean ± standard deviation (SD). The significance of the differences between the groups was determined by paired t-test and one-way/two-way analysis of variance. Cytotoxicity assay of copper chloride to F81 cells. A CCK-8 assay was used to measured cytotoxicity to F81 cells exposed to copper chloride at concentrations of 400, 200, 100, 80, 60, 40, and 20 µM during incubation at 37 °C and 5% CO2 for 24 h or 72 h. The relative activity of 0.4% DMSO-treated F81 cells was considered to be 100%, and the cytotoxicity was shown as the percentage of cell activity with respect to the DMSO mimetic treatment. Each value represents three independent replicate experiments.
Abbreviations
Figure 2
The antiviral effect of different doses of copper chloride (20-200 µM) on the 100 TCID50 FCV-infected F81 cells. After incubation for 28 h at 37 ℃ and 5% CO2, the virus titre (A) and the relative RNA levels (B) of the FCV were detected. (C) The IC50 of the copper chloride to the FCV was determined; * p <0.0332; ** p <0.0021; *** p <0.0002; and **** p <0.0001. The antiviral effect of copper chloride for different FCV strains. The F81 cells were infected with different FCV strains at 100 TCID50 and treated with 80 µM copper chloride. After incubation for 28 h at 37 °C and 5% CO2, the virus titre (A) and the relative RNA levels (B) of the FCV were detected; * p < 0.1234 and ** p < 0.0021.
Figure 6
The antiviral effect of the compound combination. (A and C) The compounds were diluted to the indicated concentrations and used in combination to treat FCV infection. The results of the RT-qPCR were statistically analyzed by the methods described above, and the effects of the drug combination were evaluated using SynergyFinder. (B and D) Different concentrations of compound interaction scores were calculated using the ZIP model.
